NI201700038A - Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos - Google Patents
Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismosInfo
- Publication number
- NI201700038A NI201700038A NI201700038A NI201700038A NI201700038A NI 201700038 A NI201700038 A NI 201700038A NI 201700038 A NI201700038 A NI 201700038A NI 201700038 A NI201700038 A NI 201700038A NI 201700038 A NI201700038 A NI 201700038A
- Authority
- NI
- Nicaragua
- Prior art keywords
- compounds
- dihydropyridin
- oxo
- alkyl
- ilo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere en forma general a los compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo (incluyendo sales de los mismos). La presente invención asímismo se refiere a las composiciones farmacéuticas y a los kits que comprenden dichos compuestos, a los usos de dichos compuestos ( incluyendo métodos de tratamiento y preparación de medicamentos), y a los procesos para preparar dichos compuestos.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055822P | 2014-09-26 | 2014-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201700038A true NI201700038A (es) | 2018-01-05 |
Family
ID=54252264
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201700038A NI201700038A (es) | 2014-09-26 | 2017-03-24 | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US10196374B2 (es) |
| EP (1) | EP3197878B1 (es) |
| JP (1) | JP6430000B2 (es) |
| KR (1) | KR101866706B1 (es) |
| CN (1) | CN107001320B (es) |
| AP (1) | AP2017009819A0 (es) |
| AR (1) | AR105549A1 (es) |
| AU (1) | AU2015323817B2 (es) |
| BR (1) | BR112017006085B1 (es) |
| CA (1) | CA2962312C (es) |
| CL (1) | CL2017000715A1 (es) |
| CO (1) | CO2017003955A2 (es) |
| CR (1) | CR20170106A (es) |
| DO (1) | DOP2017000064A (es) |
| EA (1) | EA031945B1 (es) |
| ES (1) | ES2751640T3 (es) |
| GT (1) | GT201700058A (es) |
| IL (1) | IL250886A0 (es) |
| MX (1) | MX2017003697A (es) |
| NI (1) | NI201700038A (es) |
| NZ (1) | NZ730250A (es) |
| PE (1) | PE20171110A1 (es) |
| PH (1) | PH12017500533A1 (es) |
| SG (1) | SG11201702225VA (es) |
| SV (1) | SV2017005412A (es) |
| TN (1) | TN2017000096A1 (es) |
| TW (1) | TW201619146A (es) |
| UY (1) | UY36327A (es) |
| WO (1) | WO2016046260A1 (es) |
| ZA (1) | ZA201702720B (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017161518A1 (en) * | 2016-03-23 | 2017-09-28 | Astrazeneca Ab | New physical form |
| US10626106B2 (en) | 2017-12-18 | 2020-04-21 | Gruenenthal Gmbh | Substituted pyrrolidine amides I |
| TW201927769A (zh) | 2017-12-18 | 2019-07-16 | 德商歌林達有限公司 | 經取代之吡咯啶醯胺ｉｉ |
| EP3908581A1 (en) | 2019-01-11 | 2021-11-17 | Grünenthal GmbH | Substituted pyrrolidine amides iii |
| EP3986886A2 (en) | 2019-06-19 | 2022-04-27 | Grünenthal GmbH | Substituted pyrrolidine amides v |
| EP3986885B1 (en) | 2019-06-19 | 2023-05-03 | Grünenthal GmbH | Substituted pyrrolidine amides iv |
| EP4086247A4 (en) * | 2019-12-31 | 2023-12-06 | Medshine Discovery Inc. | BENZOPYRAZOLE COMPOUND |
| US20230265078A1 (en) | 2020-07-09 | 2023-08-24 | Gruenenthal Gmbh | Substituted pyrrolidine amines and amides vi |
| CN115667237A (zh) * | 2020-07-17 | 2023-01-31 | 成都苑东生物制药股份有限公司 | 作为bet抑制剂的新型杂环化合物 |
| WO2023041695A1 (en) | 2021-09-20 | 2023-03-23 | Astrazeneca Ab | Methods of treating inflammatory diseases with a selective glucocorticoid receptor modulator |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008506669A (ja) * | 2004-07-16 | 2008-03-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 神経変性疾患の処置に適するピペリジン、ピペラジンもしくはモルホリンの二量体化合物またはそれらの７−員同族体 |
| JO2754B1 (en) * | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| US20100080786A1 (en) * | 2008-05-20 | 2010-04-01 | Markus Berger | Phenyl or Pyridinyl Substituted Indazoles Derivatives |
-
2015
- 2015-09-23 SG SG11201702225VA patent/SG11201702225VA/en unknown
- 2015-09-23 JP JP2017515945A patent/JP6430000B2/ja active Active
- 2015-09-23 PE PE2017000467A patent/PE20171110A1/es unknown
- 2015-09-23 ES ES15775130T patent/ES2751640T3/es active Active
- 2015-09-23 BR BR112017006085-0A patent/BR112017006085B1/pt active IP Right Grant
- 2015-09-23 AU AU2015323817A patent/AU2015323817B2/en active Active
- 2015-09-23 WO PCT/EP2015/071862 patent/WO2016046260A1/en active Application Filing
- 2015-09-23 CR CR20170106A patent/CR20170106A/es unknown
- 2015-09-23 AP AP2017009819A patent/AP2017009819A0/en unknown
- 2015-09-23 MX MX2017003697A patent/MX2017003697A/es active IP Right Grant
- 2015-09-23 NZ NZ730250A patent/NZ730250A/en not_active IP Right Cessation
- 2015-09-23 CN CN201580064182.1A patent/CN107001320B/zh active Active
- 2015-09-23 US US15/513,655 patent/US10196374B2/en active Active
- 2015-09-23 EP EP15775130.6A patent/EP3197878B1/en active Active
- 2015-09-23 KR KR1020177007804A patent/KR101866706B1/ko active IP Right Grant
- 2015-09-23 CA CA2962312A patent/CA2962312C/en active Active
- 2015-09-23 EA EA201790496A patent/EA031945B1/ru not_active IP Right Cessation
- 2015-09-23 TN TN2017000096A patent/TN2017000096A1/en unknown
- 2015-09-25 AR ARP150103099A patent/AR105549A1/es unknown
- 2015-09-25 TW TW104131819A patent/TW201619146A/zh unknown
- 2015-09-25 UY UY0001036327A patent/UY36327A/es not_active Application Discontinuation
-
2017
- 2017-03-02 IL IL250886A patent/IL250886A0/en active IP Right Grant
- 2017-03-08 DO DO2017000064A patent/DOP2017000064A/es unknown
- 2017-03-22 GT GT201700058A patent/GT201700058A/es unknown
- 2017-03-23 PH PH12017500533A patent/PH12017500533A1/en unknown
- 2017-03-24 SV SV2017005412A patent/SV2017005412A/es unknown
- 2017-03-24 CL CL2017000715A patent/CL2017000715A1/es unknown
- 2017-03-24 NI NI201700038A patent/NI201700038A/es unknown
- 2017-04-18 ZA ZA2017/02720A patent/ZA201702720B/en unknown
- 2017-04-24 CO CONC2017/0003955A patent/CO2017003955A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2017003955A2 (es) | Compuestos de 1-alquil-6-oxo-1,6-dihidropiridin-3-ilo y usos de los mismos | |
| ECSP17081744A (es) | Nuevos derivados hidroxiéster,un proceso para su preparación y composiciones farmacéuticas que los contienen | |
| GT201600147A (es) | Compuestos derivados y composiciones de n-azaspirocicloalcano n-heteroaril sustituido para inhibir la actividad de shp2 | |
| CO2017006214A2 (es) | Derivados de quinazolina utilizados para tratar el vih | |
| NI201600115A (es) | Derivados de sulfamoilpirrolamida y su uso como medicamentos para el tratamiento de la hepatitis b. | |
| BR112018005497A2 (pt) | compostos heterocíclicos e usos dos mesmos | |
| BR112018073384A2 (pt) | polinucleotídeos moduladores | |
| CO2017001884A2 (es) | Polimorfos de selinexor | |
| CO2018000589A2 (es) | Oxiesteroles y composiciones farmacéuticas que los contienen | |
| BR112017023161A2 (pt) | composições de ácido obeticólico e métodos de uso | |
| BR112017009497A2 (pt) | polinucleotídeos de aadc para o tratamento da doença de parkinson | |
| EA201691582A1 (ru) | Новые фармацевтические препараты | |
| BR112015022041A2 (pt) | derivados substituídos de 3-fenilpropilamina para o tratamento de doenças e distúrbios oftálmicas | |
| DOP2018000062A (es) | Piridinona dicaboxamidas para uso como inhibidores de bromodominio | |
| UY36224A (es) | Compuestos tricíclicos de imidazo-pirimidinona | |
| ECSP16074478A (es) | Compuestos novedosos | |
| CO2017000950A2 (es) | Compuestos que comprenden oligonucleótidos modificados dirigidos a mir-103 y/o mir-107 para trastornos metabólicos | |
| GT201600250A (es) | Compuestos de 1, 3, 4- tiadiazol y uso de los mismos para el tratamiento del cáncer | |
| BR112017009471A2 (pt) | síntese de copanlisib e seu sal de di-hidrocloreto. | |
| DOP2016000297A (es) | Composiciones farmacéuticas útiles para tratar enfermedades infecciosas | |
| BR112016028316A2 (pt) | composição farmacêutica oral de isotretinoina, seu processo de preparação e método de tratamento | |
| DOP2018000049A (es) | Compuestos para uso en aplicaciones antibacterianas | |
| CR20170157A (es) | Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial | |
| CL2016002267A1 (es) | Ureas asimétricas p-sustituidas y usos médicos de las mismas | |
| BR112016028083A2 (pt) | Composição oral farmacêutica de isotretinoina e seu processo de preparação |